What do Synthes trauma reps make?

DePuy Synthes Salary FAQs The average salary for a Trauma Sales Representative is $54,287 per year in United States, which is 17% lower than the average DePuy Synthes salary of $66,144 per year for this job.

What does DePuy Synthes make?

DePuy Synthes Companies are part of the Johnson & Johnson family of companies. DePuy Synthes makes orthopaedic and neuro products and services for joint reconstruction, spine, trauma, neuro, cranio-maxillofacial, power tools and biomaterials.

Is DePuy Synthes owned by Johnson and Johnson?

DePuy Synthes (/dəˈpjuː/) is a franchise of orthopaedic and neurosurgery companies. Acquired by Johnson & Johnson in 1998, its companies form part of the Johnson & Johnson Medical Devices group. DePuy develops and markets products under the Codman, DePuy Mitek, DePuy Orthopaedics and DePuy Spine brands.

What is Synthes trauma?

DePuy Synthes Trauma is a global leader in medical devices used to treat orthopaedic trauma. The company’s fixation products, including screws, plates, nails and other implants, are used to treat fractures, deformities, and tumors related to the shoulder, hand, arms, legs, hip, pelvis, condyles and feet.

How much does a DePuy Synthes Spine rep make?

The average DePuy Synthes Sales Rep earns an estimated $177,364 annually, which includes an estimated base salary of $96,319 with a $81,045 bonus. DePuy Synthes’ Sales Rep compensation is $66,846 more than the US average for a Sales Rep.

Where are J&J products made?

J&J companies employ roughly 6,000 people in China today and produce a wide range of consumer, pharmaceutical, and medical products. The companies use local market research, natural ingredients, and competitive prices to meet the needs of China’s emerging market.

Where are DePuy Synthes products made?

The Ringaskiddy, Cork manufacturing site was established in 1997. DePuy Synthes Companies of Johnson & Johnson is one of several Johnson & Johnson companies operating in Ireland, employing approximately 2,500 associates.

When did J&J Buy DePuy Synthes?

Later, in 2012, Johnson & Johnson acquired global medical device company Synthes, Inc., and combined that company with the DePuy franchise to create one of the world’s largest orthopaedic and neurological businesses.

When did DePuy and Synthes merger?

On April 27, 2011, Synthes and Johnson and Johnson DePuy agreed to a merger deal. The merger created the world’s largest orthopedic corporation. On June 13, 2012 Johnson & Johnson announced the acquisition of Synthes for $19.7 billion.

Did DePuy buy Synthes?

for a total purchase price of $19.7 billion in cash and stock. Synthes will now be integrated with the DePuy franchise to establish the DePuy Synthes Companies of Johnson & Johnson.